KIDS
insider transactionsORTHOPEDIATRICS CORP — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
Net shares · 365d
-58.2K
0 buy · 58.2K sell
Net value · 365d
-$1.0M
$0 in · $1.0M out
Sentiment · 365d
Net selling
0% buying · 100% selling
Open-market trades · 365d
5
0 buy · 58.2K sell
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Grant·A
Director
$0
11.4K sh
Own +35%
-
Grant·A
Director
$0
11.4K sh
Own +56%
-
Grant·A
Director
$0
11.4K sh
Own +136%
-
Grant·A
Director
$0
11.4K sh
Own +7%
-
Grant·A
Director
$0
11.4K sh
Own +87%
-
Grant·A
Director
$0
11.4K sh
Own +58%
-
Grant·A
Director
$0
11.4K sh
Own +54%
-
Grant·A
Director
$0
11.4K sh
Own +263%
-
Grant·A
Director
$0
11.4K sh
Own +87%
-
Grant·A
David R Bailey KEY
President and CEO
$0
119.1K sh
Own +40%
-
Other·G
General Counsel and Secretary
$0
2.5K sh
Own -2%
-
Sell·S
Gregory A Odle KEY
President of Scoliosis
$145.5K
8.4K sh · $17.25
Own -4%
-
Sell·S
Fred Hite KEY
COO and CFO
$224.1K
13.0K sh · $17.25
Own -4%
-
Sell·S
Pres. Trauma & Def. Correction
$148.3K
8.6K sh · $17.25
Own -4%
-
Sell·S
General Counsel and Secretary
$148.6K
8.6K sh · $17.25
Own -5%
-
Sell·S
David R Bailey KEY
President and CEO
$337.0K
19.5K sh · $17.25
Own -6%
-
Grant·A
Gregory A Odle KEY
President of Scoliosis
$0
47.4K sh
Own +32%
-
Grant·A
Fred Hite KEY
COO and CFO
$0
77.4K sh
Own +36%
-
Grant·A
Pres. Trauma & Def. Correction
$0
65.7K sh
Own +48%
-
Grant·A
General Counsel and Secretary
$0
47.4K sh
Own +43%
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Jun 9, 2026 | David R Pelizzon | Grant A | 11.4K | $0 |
| Jun 9, 2026 | Samuel D Riccitelli | Grant A | 11.4K | $0 |
| Jun 9, 2026 | Harold Ruf | Grant A | 11.4K | $0 |
| Jun 9, 2026 | Mark C Throdahl | Grant A | 11.4K | $0 |
| Jun 9, 2026 | Jimmy Duane Mcdonald | Grant A | 11.4K | $0 |
| Jun 9, 2026 | (Reynolds) Marie C Infante | Grant A | 11.4K | $0 |
| Jun 9, 2026 | Bryan W Hughes | Grant A | 11.4K | $0 |
| Jun 9, 2026 | Kelly Laine Fischer | Grant A | 11.4K | $0 |
| Jun 9, 2026 | George Sinclair Mitchell Dyer | Grant A | 11.4K | $0 |
| Jun 9, 2026 | David R Bailey KEY | Grant A | 119.1K | $0 |
| May 13, 2026 | Daniel J Gerritzen | Other G | 2.5K | $0 |
| Mar 16, 2026 | Gregory A Odle KEY | Sell S | 8.4K | $145.5K |
| Mar 16, 2026 | Fred Hite KEY | Sell S | 13.0K | $224.1K |
| Mar 16, 2026 | Joseph W Hauser | Sell S | 8.6K | $148.3K |
| Mar 16, 2026 | Daniel J Gerritzen | Sell S | 8.6K | $148.6K |
| Mar 16, 2026 | David R Bailey KEY | Sell S | 19.5K | $337.0K |
| Mar 15, 2026 | Gregory A Odle KEY | Grant A | 47.4K | $0 |
| Mar 15, 2026 | Fred Hite KEY | Grant A | 77.4K | $0 |
| Mar 15, 2026 | Joseph W Hauser | Grant A | 65.7K | $0 |
| Mar 15, 2026 | Daniel J Gerritzen | Grant A | 47.4K | $0 |
About KIDS insider trading
This page tracks insider transactions for ORTHOPEDIATRICS CORP (KIDS) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.